Skip to main content
Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
25.47
+0.01 (0.04%)
At close: Dec 5, 2025, 4:00 PM EST
25.25
-0.22 (-0.86%)
After-hours: Dec 5, 2025, 5:48 PM EST

Lyell Immunopharma Revenue

Lyell Immunopharma had revenue of $15.00K in the quarter ending September 30, 2025, a decrease of -55.88%. This brings the company's revenue in the last twelve months to $41.00K, down -34.92% year-over-year. In the year 2024, Lyell Immunopharma had annual revenue of $61.00K, down -53.08%.

Revenue (ttm)
$41.00K
Revenue Growth
-34.92%
P/S Ratio
13,067.32
Revenue / Employee
$137
Employees
300
Market Cap
535.76M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202461.00K-69.00K-53.08%
Dec 31, 2023130.00K-84.55M-99.85%
Dec 31, 202284.68M74.03M695.15%
Dec 31, 202110.65M2.89M37.31%
Dec 31, 20207.76M7.10M1,080.52%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

LYEL News

More News